Literature DB >> 6837723

Cultured diploid fibroblasts from patients with the nevoid basal cell carcinoma syndrome are hypersensitive to killing by ionizing radiation.

G L Chan, J B Little.   

Abstract

Nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disease. About 20% of the gene carriers studied developed medulloblastoma before the age of 5 years. Clinical follow-up of these patients, treated with radiotherapy, revealed a predisposition to radiogenic basal cell carcinomas with an unusually short latent period of 6 months to 3 years. The authors have therefore cultured skin fibroblasts from 5 NBCCS patients and measured their radiosensitivity in terms of clonogenic survival. Our results showed that, compared with 6 normal controls, the NBCCS cells were hypersensitive to X-rays. The average D0 (the inverse of the slope of the survival curve) for the NBCCS cells was 98 rads, compared with 142 rads for the normal controls and 44 rads for an ataxia telangiectasia (AT) strain. The average D10 values (the dose required to reduce survival to 10%) were 258, 351, and 123 rads for the NBCCS, normal, and AT strains, respectively. Unscheduled DNA synthesis measurements showed that NBCCS cells were not defective in excision repair of X-ray-damaged DNA. Pulse labeling index measurements showed that NBCCS cells were abnormally inhibited in the initiation of DNA synthesis following X-irradiation. The mechanisms underlying the radiosensitivity of NBCCS differ in several respects from those of AT. NBCCS appears to be potentially a useful model for studying the cellular processes that are important in radiation carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6837723      PMCID: PMC1916205     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  21 in total

1.  Studies on a new case of xeroderma pigmentosum (XP3BR) from complementation group G with cellular sensitivity to ionizing radiation.

Authors:  C F Arlett; S A Harcourt; A R Lehmann; S Stevens; M A Ferguson-Smith; W N Morley
Journal:  Carcinogenesis       Date:  1980-09       Impact factor: 4.944

2.  Defective excision repair of gamma-ray-damaged DNA in human (ataxia telangiectasia) fibroblasts.

Authors:  M C Paterson; B P Smith; P H Lohman; A K Anderson; L Fishman
Journal:  Nature       Date:  1976-04-01       Impact factor: 49.962

3.  Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity.

Authors:  A M Taylor; D G Harnden; C F Arlett; S A Harcourt; A R Lehmann; S Stevens; B A Bridges
Journal:  Nature       Date:  1975-12-04       Impact factor: 49.962

4.  Second malignant tumors after cancer in childhood.

Authors:  F P Li
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

Review 5.  Genetic and environmental interactions.

Authors:  L C Strong
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

6.  Radiation-induced skin cancer of the head and neck.

Authors:  H Martin; E Strong; R H Spiro
Journal:  Cancer       Date:  1970-01       Impact factor: 6.860

7.  Nevoid basal cell carcinoma syndrome.

Authors:  R Jackson; S Gardere
Journal:  Can Med Assoc J       Date:  1971-10-23       Impact factor: 8.262

Review 8.  Chemical carcinogenesis: a biologic perspective.

Authors:  E Farber
Journal:  Am J Pathol       Date:  1982-02       Impact factor: 4.307

9.  Neurological involvement in the nevoid basal cell carcinoma syndrome.

Authors:  C R Neblett; T A Waltz; D E Anderson
Journal:  J Neurosurg       Date:  1971-11       Impact factor: 5.115

Review 10.  The multiple nevoid basal cell carcinoma syndrome revisited.

Authors:  R J Gorlin; H O Sedano
Journal:  Birth Defects Orig Artic Ser       Date:  1971-06
View more
  2 in total

1.  Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas.

Authors:  D Schofield; D C West; D C Anthony; R Marshal; J Sklar
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

Review 2.  The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma.

Authors:  D G Evans; P A Farndon; L D Burnell; H R Gattamaneni; J M Birch
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.